Corvus Pharmaceuticals, Inc. (CRVS) NASDAQ
$5.48 (0.02) (-0.36%)
Market Cap: $342.78M
As of 09/18/24 04:00 PM EDT. Market closed.
Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ
$5.48
(0.02) (-0.36%)
Market Cap: $342.78M
As of 09/18/24 04:00 PM EDT. Market closed.
Add to Portfolio
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The company also develops CPI-818, a covalent inhibitor of ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Richard A. Miller M.D.
Full Time Employees
28
CEO Compensation (Base)
$110,309
CEO Compensation (Total)
$1.32M
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Richard A. Miller M.D.
Full Time Employees
28
CEO Compensation (Base)
$110,309
CEO Compensation (Total)
$1.32M
Address
863 Mitten Road, CA, Burlingame, 94010.
PRICE CHART FOR CORVUS PHARMACEUTICALS, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$5.26
Previous Close
$5.50
Days Range
$5.25 - $5.72
52 week range
$1.05 - $6.15
Volume
458,072
Avg. Volume (30 days)
344,320
Market Cap
$342.78M
Dividend Yield
-
P/E
(12.74)
Shares Outstanding
62,551,300
Open
$5.26
Previous Close
$5.50
Days Range
$5.25 - $5.72
52 week range
$1.05 - $6.15
Volume
458,072
Avg. Volume (30 days)
344,320
Market Cap
$342.78M
Dividend Yield
-
P/E
(12.74)
Shares Outstanding
62,551,300
FINANCIAL STATEMENTS FOR CORVUS PHARMACEUTICALS, INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR CORVUS PHARMACEUTICALS, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Jones William Benton | See Remarks | May 06, 2024 | Buy | $1.73 | 20,000 | 34,624 | 153,773 | May 07, 2024, 05:06 PM |
| MILLER RICHARD A MD | President and CEO | May 06, 2024 | Buy | $1.73 | 577,634 | 1,000,000 | 577,634 | May 07, 2024, 05:05 PM |
| Grais Linda | Director | May 15, 2023 | Buy | $2.45 | 10,000 | 24,500 | 10,000 | May 16, 2023, 04:54 PM |
| Jones William Benton | See Remarks | Dec 20, 2022 | Buy | $0.79 | 20,000 | 15,800 | 133,773 | Dec 20, 2022, 06:22 PM |
| LEA LEIV | Chief Financial Officer | Dec 14, 2022 | Buy | $0.84 | 4,000 | 3,364 | 133,238 | Dec 15, 2022, 04:33 PM |
| LEA LEIV | Chief Financial Officer | Dec 13, 2022 | Buy | $0.74 | 30,000 | 22,275 | 129,238 | Dec 15, 2022, 04:33 PM |
| MILLER RICHARD A MD | President and CEO | Dec 14, 2022 | Buy | $0.78 | 10,000 | 7,812 | 1,490,119 | Dec 15, 2022, 04:32 PM |
| MILLER RICHARD A MD | President and CEO | Dec 13, 2022 | Buy | $0.74 | 50,000 | 37,015 | 1,480,119 | Dec 15, 2022, 04:32 PM |
| MILLER RICHARD A MD | President and CEO | Sep 28, 2022 | Buy | $0.76 | 25,000 | 19,070 | 1,394,405 | Sep 28, 2022, 05:45 PM |
| MILLER RICHARD A MD | President and CEO | Sep 20, 2022 | Buy | $0.81 | 20,000 | 16,253 | 1,369,405 | Sep 20, 2022, 06:58 PM |
| MILLER RICHARD A MD | President and CEO | Jun 27, 2022 | Buy | $1.00 | 5,000 | 4,985 | 1,349,405 | Jun 28, 2022, 07:15 PM |
| MILLER RICHARD A MD | President and CEO | Jun 24, 2022 | Buy | $1.03 | 5,000 | 5,150 | 1,344,405 | Jun 28, 2022, 07:15 PM |
| MILLER RICHARD A MD | President and CEO | Jun 06, 2022 | Buy | $1.01 | 890 | 899 | 1,339,405 | Jun 06, 2022, 06:43 PM |
| MILLER RICHARD A MD | President and CEO | Jun 02, 2022 | Buy | $0.98 | 5,000 | 4,898 | 1,338,515 | Jun 06, 2022, 06:43 PM |
| MILLER RICHARD A MD | President and CEO | Mar 31, 2022 | Buy | $1.64 | 15,000 | 24,534 | 1,333,515 | Apr 01, 2022, 04:18 PM |
| LEA LEIV | Chief Financial Officer | Mar 17, 2022 | Buy | $1.65 | 13,878 | 22,899 | 99,238 | Mar 17, 2022, 07:10 PM |
| LEA LEIV | Chief Financial Officer | Mar 16, 2022 | Buy | $1.54 | 35,160 | 54,146 | 85,360 | Mar 17, 2022, 07:10 PM |
| MILLER RICHARD A MD | President and CEO | Mar 17, 2022 | Buy | $1.59 | 5,000 | 7,950 | 1,318,515 | Mar 17, 2022, 07:09 PM |
| MILLER RICHARD A MD | President and CEO | Mar 15, 2022 | Buy | $1.47 | 25,000 | 36,650 | 1,313,515 | Mar 17, 2022, 07:09 PM |
| EcoR1 Capital, LLC | 10% Owner | Oct 01, 2021 | Sale | $4.96 | 2,000,000 | 9,928,800 | 81,077 | Oct 01, 2021, 07:39 PM |
| EcoR1 Capital, LLC | 10% Owner | Sep 30, 2021 | Sale | $5.04 | 3,000,000 | 15,131,101 | 2,081,077 | Oct 01, 2021, 07:39 PM |
| ORBIMED ADVISORS LLC | Director | Sep 20, 2021 | Sale | $6.09 | 1,109,644 | 6,757,732 | 6,943,654 | Sep 22, 2021, 05:27 PM |
| Thompson Peter A. | Director | Sep 20, 2021 | Sale | $6.09 | 1,109,644 | 6,757,732 | 6,943,654 | Sep 22, 2021, 05:24 PM |
| MILLER RICHARD A MD | President and CEO | Aug 20, 2021 | Buy | $1.93 | 10,000 | 19,254 | 1,288,515 | Aug 23, 2021, 09:01 PM |
| ORBIMED ADVISORS LLC | Director | Feb 17, 2021 | Buy | $3.50 | 1,285,714 | 4,499,999 | 8,053,298 | Feb 19, 2021, 04:52 PM |
| Thompson Peter A. | Director | Feb 17, 2021 | Buy | $3.50 | 1,285,714 | 4,499,999 | 8,053,298 | Feb 19, 2021, 04:47 PM |
| MILLER RICHARD A MD | President and CEO | Feb 17, 2021 | Buy | $3.50 | 100,000 | 350,000 | 1,278,515 | Feb 17, 2021, 04:44 PM |
| Novo Holdings A/S | 10% Owner | Jul 08, 2020 | Sale | $5.37 | 741,440 | 3,985,166 | 1,389,498 | Jul 09, 2020, 04:35 PM |
| Novo Holdings A/S | 10% Owner | Jul 07, 2020 | Sale | $5.25 | 796,622 | 4,183,381 | 2,130,938 | Jul 09, 2020, 04:35 PM |
| MILLER RICHARD A MD | President and CEO | Nov 13, 2019 | Buy | $3.00 | 14,736 | 44,240 | 1,178,515 | Nov 14, 2019, 04:14 PM |
| MILLER RICHARD A MD | President and CEO | Nov 12, 2019 | Buy | $2.90 | 272 | 789 | 1,163,779 | Nov 14, 2019, 04:14 PM |
| Thompson Peter A. | Director | Aug 06, 2019 | Buy | $3.51 | 142,656 | 500,723 | 6,767,584 | Aug 08, 2019, 05:00 PM |
| ORBIMED ADVISORS LLC | Director | Aug 06, 2019 | Buy | $3.51 | 142,656 | 500,723 | 6,767,584 | Aug 08, 2019, 04:59 PM |
| MILLER RICHARD A MD | President and CEO | Aug 07, 2019 | Buy | $3.54 | 2,500 | 8,850 | 1,163,507 | Aug 08, 2019, 04:07 PM |
| MILLER RICHARD A MD | President and CEO | Aug 06, 2019 | Buy | $3.58 | 5,000 | 17,875 | 1,161,007 | Aug 08, 2019, 04:07 PM |
| Novo Holdings A/S | 10% Owner | Jul 25, 2019 | Sale | $4.00 | 1,400,000 | 5,600,000 | 2,927,560 | Jul 25, 2019, 07:21 PM |
| Novo Holdings A/S | 10% Owner | Jul 24, 2019 | Sale | $5.01 | 53,240 | 266,711 | 4,327,560 | Jul 25, 2019, 07:21 PM |
| Novo Holdings A/S | 10% Owner | Jul 23, 2019 | Sale | $5.32 | 39,716 | 211,134 | 4,380,800 | Jul 25, 2019, 07:21 PM |
| Thompson Peter A. | Director | Jul 01, 2019 | Buy | $3.91 | 59,243 | 231,640 | 6,624,928 | Jul 01, 2019, 06:16 PM |
| Thompson Peter A. | Director | Jun 28, 2019 | Buy | $3.72 | 565,178 | 2,102,462 | 6,565,685 | Jul 01, 2019, 06:16 PM |
| Thompson Peter A. | Director | Jun 27, 2019 | Buy | $3.34 | 32,923 | 109,963 | 6,000,507 | Jul 01, 2019, 06:16 PM |
| ORBIMED ADVISORS LLC | Director | Jun 28, 2019 | Buy | $3.72 | 565,178 | 2,102,462 | 6,565,685 | Jul 01, 2019, 06:15 PM |
| ORBIMED ADVISORS LLC | Director | Jun 27, 2019 | Buy | $3.34 | 32,923 | 109,963 | 6,000,507 | Jul 01, 2019, 06:15 PM |
| ORBIMED ADVISORS LLC | Director | Jul 01, 2019 | Buy | $3.91 | 59,243 | 231,640 | 6,624,928 | Jul 01, 2019, 06:15 PM |
| MILLER RICHARD A MD | President and CEO | Jun 13, 2019 | Buy | $3.52 | 343 | 1,207 | 1,144,350 | Jun 17, 2019, 04:08 PM |
| MILLER RICHARD A MD | President and CEO | Jun 14, 2019 | Buy | $3.40 | 11,657 | 39,666 | 1,156,007 | Jun 17, 2019, 04:08 PM |
| MILLER RICHARD A MD | President and CEO | Jun 11, 2019 | Buy | $3.67 | 6,000 | 22,020 | 1,144,007 | Jun 11, 2019, 04:55 PM |
| MILLER RICHARD A MD | President and CEO | Jun 07, 2019 | Buy | $3.37 | 9,212 | 31,019 | 1,138,007 | Jun 11, 2019, 04:55 PM |
| LEA LEIV | Chief Financial Officer | Jun 07, 2019 | Buy | $3.38 | 10,000 | 33,800 | 50,200 | Jun 10, 2019, 04:12 PM |
| LEA LEIV | Chief Financial Officer | Jun 06, 2019 | Buy | $3.56 | 15,500 | 55,180 | 40,200 | Jun 10, 2019, 04:12 PM |
| MILLER RICHARD A MD | President and CEO | Dec 27, 2018 | Buy | $3.29 | 20,000 | 65,884 | 1,128,795 | Dec 31, 2018, 04:16 PM |
| LEA LEIV | Chief Financial Officer | Dec 21, 2018 | Buy | $4.15 | 24,700 | 102,409 | 24,700 | Dec 27, 2018, 04:08 PM |
| MILLER RICHARD A MD | President and CEO | Dec 20, 2018 | Buy | $4.39 | 10,000 | 43,950 | 1,108,795 | Dec 26, 2018, 04:05 PM |
| MILLER RICHARD A MD | President and CEO | Dec 06, 2018 | Buy | $5.99 | 5,000 | 29,934 | 1,118,795 | Dec 10, 2018, 04:05 PM |
| MILLER RICHARD A MD | President and CEO | Dec 04, 2018 | Buy | $5.95 | 1,502 | 8,937 | 1,113,795 | Dec 06, 2018, 04:06 PM |
| Thompson Peter A. | Director | Mar 12, 2018 | Buy | $8.50 | 588,235 | 4,999,998 | 5,967,584 | Mar 14, 2018, 02:05 PM |
| ORBIMED ADVISORS LLC | Director | Mar 12, 2018 | Buy | $8.50 | 588,235 | 4,999,998 | 5,967,584 | Mar 14, 2018, 01:58 PM |
| Novo Holdings A/S | 10% Owner | Mar 12, 2018 | Buy | $8.50 | 1,176,470 | 9,999,995 | 4,420,516 | Mar 13, 2018, 05:12 PM |
| Gould Terry P | Director | Mar 12, 2018 | Buy | $8.50 | 588,235 | 4,999,998 | 236,128 | Mar 13, 2018, 04:07 PM |
| ADAMS STREET PARTNERS LLC | 10% Owner | Mar 12, 2018 | Buy | $8.50 | 588,235 | 4,999,998 | 236,128 | Mar 13, 2018, 03:30 PM |
| MILLER RICHARD A MD | President and CEO | Mar 12, 2018 | Buy | $8.50 | 100,000 | 850,000 | 1,112,293 | Mar 12, 2018, 04:05 PM |
| MILLER RICHARD A MD | President and CEO | Nov 20, 2017 | Buy | $10.78 | 10,000 | 107,850 | 1,012,293 | Nov 22, 2017, 04:06 PM |
| Novo Holdings A/S | 10% Owner | Jun 23, 2017 | Buy | $10.95 | 20,000 | 219,000 | 3,244,046 | Jun 27, 2017, 04:52 PM |
| MILLER RICHARD A MD | President and CEO | Jun 12, 2017 | Buy | $9.82 | 11,216 | 110,185 | 997,293 | Jun 13, 2017, 04:06 PM |
| MILLER RICHARD A MD | President and CEO | Jun 09, 2017 | Buy | $9.92 | 8,784 | 87,174 | 986,077 | Jun 13, 2017, 04:06 PM |
| MILLER RICHARD A MD | President and CEO | Jun 13, 2017 | Buy | $9.95 | 5,000 | 49,725 | 1,002,293 | Jun 13, 2017, 04:06 PM |
| Thompson Peter A. | Director | Jun 24, 2016 | Buy | $12.99 | 900 | 11,691 | 5,379,349 | Jun 27, 2016, 06:51 PM |
| Thompson Peter A. | Director | Jun 23, 2016 | Buy | $12.92 | 100 | 1,292 | 5,378,449 | Jun 27, 2016, 06:51 PM |
| ORBIMED ADVISORS LLC | Director | Jun 24, 2016 | Buy | $12.99 | 900 | 11,691 | 5,379,349 | Jun 27, 2016, 06:47 PM |
| ORBIMED ADVISORS LLC | Director | Jun 23, 2016 | Buy | $12.92 | 100 | 1,292 | 5,378,449 | Jun 27, 2016, 06:47 PM |
| Thompson Peter A. | Director | Jun 21, 2016 | Buy | $12.87 | 26,083 | 335,688 | 5,378,349 | Jun 21, 2016, 07:00 PM |
| Thompson Peter A. | Director | Jun 17, 2016 | Buy | $12.48 | 12,300 | 153,504 | 5,352,266 | Jun 21, 2016, 07:00 PM |
| ORBIMED ADVISORS LLC | Director | Jun 17, 2016 | Buy | $12.48 | 12,300 | 153,504 | 5,352,266 | Jun 21, 2016, 06:55 PM |
| ORBIMED ADVISORS LLC | Director | Jun 21, 2016 | Buy | $12.87 | 26,083 | 335,688 | 5,378,349 | Jun 21, 2016, 06:55 PM |
| Thompson Peter A. | Director | Jun 16, 2016 | Buy | $12.04 | 5,000 | 60,200 | 5,339,966 | Jun 16, 2016, 06:05 PM |
| Thompson Peter A. | Director | Jun 15, 2016 | Buy | $11.94 | 5,000 | 59,700 | 5,334,966 | Jun 16, 2016, 06:05 PM |
| Thompson Peter A. | Director | Jun 14, 2016 | Buy | $12.71 | 10,000 | 127,100 | 5,329,966 | Jun 16, 2016, 06:05 PM |
| ORBIMED ADVISORS LLC | Director | Jun 16, 2016 | Buy | $12.04 | 5,000 | 60,200 | 5,339,966 | Jun 16, 2016, 05:59 PM |
| ORBIMED ADVISORS LLC | Director | Jun 15, 2016 | Buy | $11.94 | 5,000 | 59,700 | 5,334,966 | Jun 16, 2016, 05:59 PM |
| ORBIMED ADVISORS LLC | Director | Jun 14, 2016 | Buy | $12.71 | 10,000 | 127,100 | 5,329,966 | Jun 16, 2016, 05:59 PM |
| Thompson Peter A. | Director | Jun 10, 2016 | Buy | $12.98 | 20,000 | 259,600 | 5,319,966 | Jun 13, 2016, 05:23 PM |
| Thompson Peter A. | Director | Jun 09, 2016 | Buy | $12.95 | 30,000 | 388,500 | 5,299,966 | Jun 13, 2016, 05:23 PM |
| ORBIMED ADVISORS LLC | Director | Jun 10, 2016 | Buy | $12.98 | 20,000 | 259,600 | 5,319,966 | Jun 13, 2016, 05:18 PM |
| ORBIMED ADVISORS LLC | Director | Jun 09, 2016 | Buy | $12.95 | 30,000 | 388,500 | 5,299,966 | Jun 13, 2016, 05:18 PM |
| Thompson Peter A. | Director | May 20, 2016 | Buy | $13.09 | 4,716 | 61,732 | 5,269,966 | May 24, 2016, 04:48 PM |
| ORBIMED ADVISORS LLC | Director | May 20, 2016 | Buy | $13.09 | 4,716 | 61,732 | 5,269,966 | May 24, 2016, 04:37 PM |
| ORBIMED ADVISORS LLC | Director | May 19, 2016 | Buy | $12.13 | 2,600 | 31,525 | 5,265,250 | May 20, 2016, 05:21 PM |
| ORBIMED ADVISORS LLC | Director | May 18, 2016 | Buy | $11.55 | 4,200 | 48,510 | 5,262,650 | May 20, 2016, 05:21 PM |
| Thompson Peter A. | Director | May 19, 2016 | Buy | $12.13 | 2,600 | 31,525 | 5,265,250 | May 20, 2016, 04:27 PM |
| Thompson Peter A. | Director | May 18, 2016 | Buy | $11.55 | 4,200 | 48,510 | 5,262,650 | May 20, 2016, 04:27 PM |
| MILLER RICHARD A MD | President and CEO | May 13, 2016 | Buy | $9.94 | 300 | 2,981 | 1,077,293 | May 16, 2016, 06:38 PM |
| MILLER RICHARD A MD | President and CEO | May 12, 2016 | Buy | $10.00 | 30,000 | 300,000 | 1,076,993 | May 16, 2016, 06:38 PM |
| Novo A/S | 10% Owner | May 12, 2016 | Buy | $10.00 | 70,000 | 700,000 | 3,224,046 | May 16, 2016, 05:01 PM |
| Novo A/S | 10% Owner | Mar 29, 2016 | Buy | $15.00 | 666,666 | 9,999,990 | 3,154,046 | Mar 30, 2016, 01:07 PM |
| ORBIMED ADVISORS LLC | Director | Mar 29, 2016 | Buy | $15.00 | 550,000 | 8,250,000 | 5,258,450 | Mar 29, 2016, 12:21 PM |
| Thompson Peter A. | Director | Mar 29, 2016 | Buy | $15.00 | 550,000 | 8,250,000 | 5,258,450 | Mar 29, 2016, 12:00 PM |
| ADAMS STREET PARTNERS LLC | 10% Owner | Mar 29, 2016 | Buy | $15.00 | 200,000 | 3,000,000 | 736,033 | Mar 29, 2016, 11:54 AM |
| Gould Terry P | Director | Mar 29, 2016 | Buy | $15.00 | 200,000 | 3,000,000 | 736,033 | Mar 29, 2016, 11:39 AM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
FUNDS WITH A POSITION IN CORVUS PHARMACEUTICALS, INC.
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 6,943,654 | 0.25% | No change | Other |
| RENAISSANCE TECHNOLOGIES LLC | 563,932 | 0.00174% | -11.48% | Other |
| BLACKROCK INC. | 562,024 | 0.00002% | 7.47% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 460,140 | 0.00007% | 23.77% | Other |
CHANGE IN SHARES OUTSTANDING FOR CORVUS PHARMACEUTICALS, INC.
STOCK BUYBACKS FOR CORVUS PHARMACEUTICALS, INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
-0.02%
1Q
09/30/2023
0.14%
2Q
06/30/2023
3.24%
3Q
03/31/2023
5.33%
4Q
12/31/2022
5.34%
5Q
09/30/2022
5.34%
6Q
06/30/2022
5.34%
7Q
03/31/2022
5.34%
8Q
12/31/2021
5.22%
9Q
09/30/2021
11.59%
10Q
06/30/2021
16.08%
11Q
03/31/2021
42.08%
12Q
12/31/2020
65.35%
13Q
09/30/2020
66.23%
14Q
06/30/2020
66.64%
15Q
03/31/2020
66.73%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CORVUS PHARMACEUTICALS, INC.
LOADING...